Sandbox: differentialdx maria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align=center | |||
|valign=top| | |||
|+ | |||
|- | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Procedure}} | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Advantages}} | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Disadvantages}} | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| [[Thoracotomy]] (surgical opening of the chest) | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Allows the most thorough inspection and sampling of lymph node stations, may be followed by resection of tumor, if feasible | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Most invasive approach, not indicated for staging alone, significant risk of procedure-related morbidity | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| Left parasternal mediastinotomy (or anterior mediastinotomy) | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Permits evaluation of the aortopulmonary window lymph nodes | |||
|style="padding: 5px 5px; background: #F5F5F5;"| More invasive; false-negative rate approximately 10%. | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| Chamberlain procedure | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Access to station 5 ([[aortopulmonary window]] lymph node) | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Limited applications, invasive | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| [[Mediastinoscopy|Cervical mediastinoscopy]] | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Still considered the gold standard (usual comparitor) by many, excellent for 2RL 4RL | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Does not cover all medastinal lymph node stations, particularly subcarinal lymph nodes (station 7), paraesophageal and pulmonary ligament lymph nodes (stations 8 and 9), the aortopulmonary window lymph nodes (station 5), and the anterior mediastinal lymph nodes (station 6); false-negative rate approximately 20%; invasive | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| [[Thoracoscopy|Video-assisted thoracoscopy]] | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Good for inferior mediastinum, station 5 and 6 lymph nodes | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Invasive, does not cover superior anterior mediastinum | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| Transthoracic percutaneous [[fine needle aspiration]] (FNA) under CT guidance | |||
|style="padding: 5px 5px; background: #F5F5F5;"| More widely available than some other methods | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Traverses a lot of lung tissue, therefore high pneumothorax risk, some lymph node stations inaccessible | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| [[Bronchoscopy]] with blind transbronchial FNA (Wang needle) | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Less invasive than above methods | |||
|style="padding: 5px 5px; background: #F5F5F5;"| Relatively low yield, not widely practiced, bleeding risk | |||
|- | |||
|} | |||
{| style="border:1px solid black; border-collapse:collapse" border="1" cellpadding="5" | {| style="border:1px solid black; border-collapse:collapse" border="1" cellpadding="5" | ||
Line 4: | Line 45: | ||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Procedure}} | ! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Procedure}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Advantages}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Advantages}} | ||
style="padding: 5px 5px; background: #F5F5F5;"| | |||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| Endobronchial ultrasound (EBUS) | |style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;"| Endobronchial ultrasound (EBUS) |
Revision as of 16:08, 25 February 2016
Procedure | Advantages | Disadvantages |
---|---|---|
Thoracotomy (surgical opening of the chest) | Allows the most thorough inspection and sampling of lymph node stations, may be followed by resection of tumor, if feasible | Most invasive approach, not indicated for staging alone, significant risk of procedure-related morbidity |
Left parasternal mediastinotomy (or anterior mediastinotomy) | Permits evaluation of the aortopulmonary window lymph nodes | More invasive; false-negative rate approximately 10%. |
Chamberlain procedure | Access to station 5 (aortopulmonary window lymph node) | Limited applications, invasive |
Cervical mediastinoscopy | Still considered the gold standard (usual comparitor) by many, excellent for 2RL 4RL | Does not cover all medastinal lymph node stations, particularly subcarinal lymph nodes (station 7), paraesophageal and pulmonary ligament lymph nodes (stations 8 and 9), the aortopulmonary window lymph nodes (station 5), and the anterior mediastinal lymph nodes (station 6); false-negative rate approximately 20%; invasive |
Video-assisted thoracoscopy | Good for inferior mediastinum, station 5 and 6 lymph nodes | Invasive, does not cover superior anterior mediastinum |
Transthoracic percutaneous fine needle aspiration (FNA) under CT guidance | More widely available than some other methods | Traverses a lot of lung tissue, therefore high pneumothorax risk, some lymph node stations inaccessible |
Bronchoscopy with blind transbronchial FNA (Wang needle) | Less invasive than above methods | Relatively low yield, not widely practiced, bleeding risk |
Procedure | Advantages
style="padding: 5px 5px; background: #F5F5F5;"| | |
---|---|---|
Endobronchial ultrasound (EBUS) |
|
|
Endoscopic ultrasound (EUS) |
|
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Pulmonary tuberculosis | Chronic cough, weight loss, hemoptysis, nocturnal diaphoresis, dyspnea | In pulmonary tuberculosis, differentiating features include: increase in diameter despite optimal medical therapy, patients age is usually younger, hemoptisis is an early feature, and CXR anatomical predilection for upper lobes |
Lung abscess | Chronic cough, weight loss, hemoptysis, and dyspnea | In lung abscess, differentiating features include: acute or subacute onset, CXR anatomical predilection for upper lobes, and usually resolve with antibiotic |
Pneumonia | Chronic cough, weight loss, hemoptysis, and dyspnea | In pneumonia, differentiating features include: good response to antibiotics, acute onset, predilection on CXR is consolidation, laboratory markers indicate infection. |
Fungal infection | Chronic cough, weight loss, hemoptysis, and dyspnea | In fungal infection, differentiating features include: CXR findings: air-cresecent sign, no response to antibioitcs, and mimcs tuberculosis. |
Chronic eosinophilic pneumonia | Chronic cough, weight loss, hemoptysis, and dyspnea | In chronic eosinophilic pneumonia , differentiating features include: followed by a parasite infection or medication exposure, and increased serum IgE levels |
Age-adjusted incidence of lung cancer by histological type Adapted from Wikipedia [1] |
|||
---|---|---|---|
All types | 66.9 | ||
Adenocarcinoma | 22.1 | ||
Squamous-cell carcinoma | 14.4 |
Age-adjusted incidence of lung cancer by histological type Adapted from Wikipedia [1] |
|||
---|---|---|---|
Type | Incidence per 100,000 per year | ||
All types |
66.9 | ||
Adenocarcinoma |
22.1 | ||
Squamous-cell carcinoma |
14.4 |
Classification: Mucoepidermoid Carcinomas Adapted from Radiopedia [2] |
|||
---|---|---|---|
Salivary gland-confined carcinomas |
|
| |
|
| ||
Other organ mucoepidermoid carcinomas |
|
WHO histological classification system Adapted from WHO/IARC (2006) [2] |
|||
---|---|---|---|
Main types | Subtypes | Prevalence | |
Adenocarcinoma |
|
| |
Squamous cell carcinoma |
|
| |
Large cell carcinoma |
|
| |
Less common types | |||
Adenosquamous carcinoma |
|
| |
Sarcomatoid carcinoma |
|
| |
Carcinoid tumor |
|
| |
Salivary gland tumor |
|
|
Genes | Presence in non small cell-lung cancers |
---|---|
EGFR |
|
KRAS |
|
ALK |
|
HER2 |
|
BRAF |
|
ROS-1 |
|
Classification | ||
---|---|---|
Salivary gland-confined carcinomas |
|
|
|
| |
Other organ mucoepidermoid carcinomas |
|
Mucoepidermoid carcinoma staging | |
---|---|
Tumor |
|
| |
| |
| |
| |
Nodes |
|
| |
| |
| |
| |
Overall stage |
|
| |
| |
| |
| |
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Benign mixed tumor | Painless parotid swelling and facial deformity | In benign mixed tumor , differentiating features include: histopathological findings |
Warthin tumor | Painless swelling and facial deformity | In warthin tumor differentiating features include: multicentric presentation (20%) and are usually small (1-4 cm), highly associated with smoking |
Adenoid cystic carcinoma | Swelling on salivary gland and facial deformity | In adenoid cystic carcinoma, differentiating features include: tendency for perineural extension, distribution, and mainly occur in relation to the airways |
Metastasis | Painless swelling and facial deformity | In metastasis, differentiating features include: primary tumor origin, and histopathological findings. |
Type of tumor | Age | Location | Histological features | Imaging features | Origin | Bone/Cartilage |
---|---|---|---|---|---|---|
Osteoma | 40-50 years | Skull bones | Matured lamellar bone | Sclerotic | Benign | Bone |
Osteoid osteoma | 10-20 years | Short and long bone diaphysis | Osteiod outlined by osteoblasts, incorporated in a fibrous stroma | Sclerotic | Benign | Bone |
Osteosarcoma | 11-40 years | Long bones metaphysis | Osteoid and bone formed of malignant osteoblasts and fibroblasts | Sclerotic | Malignant | Bone |
Chondroma | 30-60 years | Small tubular bones of the hands and feet | Maturated hyaline cartilage (enchondroma/ecchondroma), preserving lobulation | Well-defined | Malignant | Cartilage |
Chondrosarcoma | 30-60 years | Long bones metaphysic, axial skeleton | Immature cartilage, no preserving lobulation, cells arranged in groups of two or four, with atypia and mitosis | Well-defined | Malignant | Cartilage |
Ewing sarcoma | 5-25 years | Long bones diaphysis | Small, round, undifferentiated cells, no stroma, a lot of capillary arrangement. | Ill-defined | Malignant | Bone |
Giant cell tumor | 20-40 years | Knee | Multinucleated giant cells, fusiform cells, mononuclear cells. | Well-defined | Malignant | Bone |
Metastases | 50-90 years | No site predilection | Frequently adenocarcinomas. Metastases can be blastic or lytic depending on the tumor origin | Sclerotic | Malignant | Bone |
Stage | Description |
---|---|
I |
|
II |
|
III |
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Enchondroma |
|
|
Chondroblastoma |
|
|
Periosteal chondroma |
|
|
Chondromyxoid fibroma |
|
|
Type of osteochondroma | Features |
---|---|
Solitary osteochondroma |
|
Multiple osteochondromas (hereditary) |
|
Genes implicated in HNPCC | Frequency of mutations in HNPCC families | Locus |
---|---|---|
MSH2 | approximately 60% | 2p22 |
MLH1 | approximately 30% | 3p21 |
MSH6 | 7-10% | 2p16 |
PMS2 | relatively infrequent | 7p22 |
PMS1 | case report | 2q31-q33 |
TGFBR2 | case report | 3p22 |
MLH3 | disputed | 14q24.3 |
Type of osteoid osteoma | Characteristics |
---|---|
Intracortical | Dense sclerosis around the nidus |
Periosteal | Periosteal reaction |
Cancellous (medullary) | Produces very little reactive bone |
Subarticular | Simulates arthritis as it produces synovial reactions |
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Osteoblastoma |
|
|
Brodie abscess |
|
|
Osteosarcoma |
|
|
Enostosis |
|
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Fibrous dysplasia |
|
|
Osteoblastoma |
|
|
Adamantinomas |
|
|
Chronic sinusitis |
|
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Cardiac tamponade |
|
|
Chronic obstructive pulmonary disease |
|
|
Mediastinitis |
|
|
Pneumonia |
|
|
Acute respiratory distress syndrome |
|
|
Syphilis |
|
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Familial adenomatous polyposis (FAP) |
|
|
Juvenile polyposis |
|
|
Cowden syndrome |
|
|
- ↑ 1.0 1.1 Lung Cancer Epidemiology. Wikipedia. https://en.wikipedia.org/wiki/Lung_cancer Accessed on February 17, 2016
- ↑ 2.0 2.1 2.2 Mucoepidermoid carcinoma. Radiopedia. Dr Frank Gailliard. http://radiopaedia.org/articles/mucoepidermoid-carcinoma-of-salivary-glands Accessed on February 17, 2016
- ↑ AJCC System for Staging of Benign and Malignant Salivary Gland Tumors. AJCC Accessed on February 18, 2016